Skip to content
Screener

Cash & Equivalents at other companies

Universal Logistics Holdings, Inc. logo
Universal Logistics Holdings, Inc.ULH
$17.92M-13.0%
Forward Air logo
Forward AirFWRD
$139.45M+46.3%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$461.74M+48.9%
Landstar System logo
Landstar SystemLSTR
$294.35M-18.1%
Covenant Logistics Group logo
Covenant Logistics GroupCVLG
$2.62M+1,729%
RXO logo
RXORXO
$16M-15.8%

Other financials

Income statement

See full
Revenue$67.4M+87.4%
Gross profit$14.1M+100%
Operating income-$3.0M+47.7%
Net income$2.2M+162%
EPS (diluted)$0.03+175%

Balance sheet

See full
Total debt$4.5M-50.7%
Total equity$285.7M+30.0%
Total assets$327.6M+30.8%

Cash flow

See full
Operating cash flow$3.9M+1,679%
CapEx$5.2M+98.1%
Free cash flow-$1.3M+54.8%

Valuation

See full
Market cap$512.22M+40.4%
Enterprise value$457.7M
P/E9.8×
P/S

Profitability

See full
Gross margin21.7%+1.3pp
Operating margin-7.8%-2.8pp
Net margin21%+13.6pp
FCF margin-22.4%+1,712pp

Returns & leverage

See full
Return on equity15.6%+10.0pp
Debt / equity0.0×
Current ratio5.9×-1.0×

Where this comes from

Reported directly by Strata Critical Medical in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Strata Critical Medical’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 11:53 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-031032
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Effect of foreign exchange rate changes on cash balances126
Net increase in cash and cash equivalents and restricted cash27,75516,041
Cash and cash equivalents and restricted cash - beginning31,23219,647
Cash and cash equivalents and restricted cash - ending$58,987$35,688
Reconciliation to consolidated balance sheets (includes discontinued operations; see Note 4)
Cash and cash equivalents$58,723$34,830
Restricted cash264858
Total cash and cash equivalents and restricted cash$58,987$35,688

Item 1. Financial Statements

FAQ

What is Strata Critical Medical's cash & equivalents?
Strata Critical Medical (SRTA) reported cash & equivalents of $58.99M in Q1 2026.
How has Strata Critical Medical's cash & equivalents changed year-over-year?
Strata Critical Medical's cash & equivalents increased by 65.3% year-over-year, from $35.69M to $58.99M.
What is the long-term trend for Strata Critical Medical's cash & equivalents?
Over 5 years (2020 to 2025), Strata Critical Medical's cash & equivalents has grown at a 24.8% compound annual growth rate (CAGR), from $10.34M to $31.23M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Strata Critical Medical's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude